NASDAQ:FOLD

Amicus Therapeutics Stock Forecast

etoro logo Buy FOLD
*Your capital is at risk
$9.42
-0.0600 (-0.633%)
At Close: Nov 17, 2025
AI Analysis AI Analysis of FOLD
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Red day on Monday for Amicus Therapeutics
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Oct 20, 2025 Gain 11.61%

The Amicus Therapeutics stock price fell by -0.633% on the last day (Monday, 17th Nov 2025) from $9.48 to $9.42. During the last trading day the stock fluctuated 2.39% from a day low at $9.42 to a day high of $9.65. The price has risen in 6 of the last 10 days and is up by 6.32% over the past 2 weeks. Volume has increased on the last day by 284 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 3 million shares were bought and sold for approximately $27.77 million.

The stock lies in the upper part of a wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $9.51 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 22.20% during the next 3 months and, with a 90% probability hold a price between $10.51 and $11.62 at the end of this 3-month period.

FOLD Signals & Forecast

The Amicus Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $9.27 and $8.63. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, November 14, 2025, and so far it has fallen -0.633%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Amicus Therapeutics stock

On the downside, the stock finds support just below today's level from accumulated volume at $8.90 and $8.33. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Amicus Therapeutics finds support just below today's level at $8.90. If this is broken, then the next support from accumulated volume will be at $8.33 and $7.71.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.225 between high and low, or 2.39%. For the last week, the stock has had daily average volatility of 3.33%.

Our recommended stop-loss: $9.14 (-2.92%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (FOLD) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Amicus Therapeutics to open at $9.50, and during the day (based on 14 day Average True Range), to move between $9.25 and $9.59, which gives a possible trading interval of +/-$0.341 (+/-3.69%) up or down from last closing price. If Amicus Therapeutics takes out the full calculated possible swing range there will be an estimated 3.69% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $9.48 (0.64%) than the support at $8.90 (5.52%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Amicus Therapeutics stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Amicus Therapeutics stock to perform well in the short-term.

Current score: 3.421 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $9.50 ( 0.796%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

FOLD Performance

Trading levels for FOLD

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 9.72 3.18%
R2 9.63 2.27%
R1 9.58 1.71%
Price 9.42
S1 9.41 -0.116%
S2 9.36 -0.680%
S3 9.27 -1.59%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 9.48 0.637%
Price 9.42
S1 8.90 -5.52%
S2 8.33 -11.57%
S3 7.71 -18.15%

FAQ

What is the symbol for Amicus Therapeutics Stock and on which exchange is it traded?
The symbol for Amicus Therapeutics is FOLD and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Amicus Therapeutics Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Amicus Therapeutics stock to perform well in the short-term.

How to buy Amicus Therapeutics Stock?
Amicus Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Amicus Therapeutics Stock.

What's the current price of Amicus Therapeutics Stock?
As of the end of day on the Nov 17, 2025, the price of an Amicus Therapeutics (FOLD) share was $9.42.

What is the 52-week high and low for Amicus Therapeutics Stock?
The 52-week high for Amicus Therapeutics Stock is $10.36 and the 52-week low is $5.51.

What is the market capitalization of Amicus Therapeutics Stock?
As of the Nov 17, 2025, the market capitalization of Amicus Therapeutics is 2.906B.

When is the next earnings date for Amicus Therapeutics?
The upcoming earnings date for Amicus Therapeutics is Feb 18, 2026.
Click to get the best stock tips daily for free!
ABOUT AMICUS THERAPEUTICS
Amicus Therapeutics
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzym...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE